
Pubmed-entry ::= {
  pmid 29355035,
  medent {
    em std {
      year 2018,
      month 1,
      day 23,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Simultaneous targeting therapy for lung metastasis and breast
 tumor by blocking the NF-kappaB signaling pathway using Celastrol-loaded
 micelles."
      },
      authors {
        names std {
          {
            name ml "Zhao Y",
            affil str "a Ocean College , Zhejiang University , Zhoushan ,
 China."
          },
          {
            name ml "Tan Y",
            affil str "a Ocean College , Zhejiang University , Zhoushan ,
 China."
          },
          {
            name ml "Meng T",
            affil str "b College of Pharmaceutical Science , Zhejiang
 University , Hangzhou , China."
          },
          {
            name ml "Liu X",
            affil str "b College of Pharmaceutical Science , Zhejiang
 University , Hangzhou , China."
          },
          {
            name ml "Zhu Y",
            affil str "a Ocean College , Zhejiang University , Zhoushan ,
 China."
          },
          {
            name ml "Hong Y",
            affil str "c The First Affiliated Hospital, College of
 Pharmaceutical Medicine , Zhejiang University , Hangzhou , China."
          },
          {
            name ml "Yang X",
            affil str "b College of Pharmaceutical Science , Zhejiang
 University , Hangzhou , China."
          },
          {
            name ml "Yuan H",
            affil str "b College of Pharmaceutical Science , Zhejiang
 University , Hangzhou , China."
          },
          {
            name ml "Huang X",
            affil str "d Department of Pharmacy, School of Medicine Science ,
 Jiaxing University , Zhejiang , China."
          },
          {
            name ml "Hu F",
            affil str "a Ocean College , Zhejiang University , Zhoushan ,
 China.; b College of Pharmaceutical Science , Zhejiang University , Hangzhou
 , China."
          }
        }
      },
      from journal {
        title {
          iso-jta "Drug Deliv",
          ml-jta "Drug Deliv",
          issn "1521-0464",
          name "Drug delivery"
        },
        imp {
          date std {
            year 2018,
            month 11
          },
          volume "25",
          issue "1",
          pages "341-352",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus other,
              date std {
                year 2018,
                month 1,
                day 23,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 1,
                day 23,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 8,
                day 7,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29355035,
        doi "10.1080/10717544.2018.1425778",
        other {
          db "pmc",
          tag str "PMC6058533"
        },
        other {
          db "ELocationID doi",
          tag str "10.1080/10717544.2018.1425778"
        }
      }
    },
    abstract "Metastasis is one of the major obstacles for successful therapy
 of breast tumor. To inhibit the metastasis and growth of breast tumor
 simultaneously, a Celastrol (Cela) loaded glucolipid-like conjugates
 (CSOSA/Cela) with alphavbeta3-ligand Tetraiodothyroacetic acid (TET)
 modification (TET-CSOSA/Cela) were established to block nuclear factor-kappa
 B (NF-kappaB) signaling pathway. The distribution of TET-CSOSA was remarkably
 increased in lung metastasis and primary tumor of 4T1 tumor-bearing mice by
 means of alphavbeta3 receptor-mediated interaction. The results demonstrated
 that TET-CSOSA/Cela significantly suppressed Bcl-2 activation of lung
 metastatic cells and reduced MMP-9 expression of 4T1 breast tumor cells by
 blocking NF-kappaB. The inhibitory rates of TET-CSOSA/Cela against lung
 metastasis and primary tumor were raised to 90.72 and 81.15%, compared to
 those of Celastrol (72.15 and 46.40%), respectively. All results demonstrated
 the alphavbeta3 receptor targeted TET-CSOSA/Cela micelles exhibited great
 potential in treating lung metastasis and primary tumor simultaneously via
 blocking NF-kappaB signaling pathway.",
    mesh {
      {
        term "Animals"
      },
      {
        term "Antineoplastic Agents",
        qual {
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      },
      {
        term "Breast Neoplasms",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Cell Line, Tumor"
      },
      {
        term "Female"
      },
      {
        term "Humans"
      },
      {
        term "Integrin alphaVbeta3",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Lung Neoplasms",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Mice"
      },
      {
        term "Mice, Inbred BALB C"
      },
      {
        term "Micelles"
      },
      {
        term "NF-kappa B",
        qual {
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Neoplasm Metastasis",
        qual {
          {
            subh "drug therapy"
          }
        }
      },
      {
        term "Signal Transduction",
        qual {
          {
            mp TRUE,
            subh "drug effects"
          }
        }
      },
      {
        term "Thyroxine",
        qual {
          {
            subh "analogs & derivatives"
          },
          {
            subh "pharmacology"
          }
        }
      },
      {
        term "Triterpenes",
        qual {
          {
            mp TRUE,
            subh "pharmacology"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Antineoplastic Agents"
      },
      {
        type nameonly,
        name "Integrin alphaVbeta3"
      },
      {
        type nameonly,
        name "Micelles"
      },
      {
        type nameonly,
        name "NF-kappa B"
      },
      {
        type nameonly,
        name "Triterpenes"
      },
      {
        type cas,
        cit "L8GG98663L",
        name "tripterine"
      },
      {
        type cas,
        cit "PA7UX1FFYQ",
        name "tetraiodothyroacetic acid"
      },
      {
        type cas,
        cit "Q51BO43MG4",
        name "Thyroxine"
      }
    },
    pmid 29355035,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


